“Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy”. 2022. Farmeconomia. Health Economics and Therapeutic Pathways 23 (1). https://doi.org/10.7175/fe.v23i1.1510.